The Transradial Access Devices market overview is projected to grow from USD 1.61 Billion in 2023 to USD 2.90 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.20% during the forecast period (2023 - 2032).

COVID-19 scenario analysis:

To take care of infected population, the demand for medical supplies is increasing. Respiratory support devices such as atomizer, life-support machine, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With rise in number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both from healthcare professionals and civil population for precautionary measures. Manufacturers of these products have a chance to capitalize this increased demand of medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Considering these factors, COVID -19 is expected to have significant impact on Transradial Access Market.

Regional Analysis

The global transradial access devices market research report consists of regions, namely, the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas dominated the global transradial access devices market owing to the use of transradial access devices for detection of cardiovascular diseases along with the demand for early diagnosis. Transradial Access Devices Market Size was valued at USD 1.5 Billion in 2022.

The European region is the second largest market for global transradial access devices due to surging cases of obesity along with the increasing number of chemotherapy procedures and growing use of radial access devices in pediatric patients. The wide scope of application for transradial access devices is a factor that is expected to be responsible for the rapid growth of the market.

The German market is expected to dominate the global transradial access devices market owing to the increase in the prevalence of target diseases coupled with the increasing number of research studies on vascular access devices in Germany.

The implementation of various healthcare reforms such as the Patient Protection and Affordable Care Act (PPACA) and high burden of Cardiovascular Diseases (CVDS) in India coupled with the increasing investments in the Asia Pacific region are the factors favoring the growth of transradial access devices in the Asia Pacific region

The Middle East and Africa is projected to show steady growth in this market due to the strengthening of the healthcare infrastructure in the Middle East and rising prevalence of cancer in Africa along with the subsequent rise in the number of chronic diseases such as cardiovascular diseases, cancer, rheumatoid arthritis, and inflammatory bowel disease.

Segmentation

The global transradial access devices market is segmented by product, application, disease area, and end-user.

Based on product, the global transradial access devices market is classified as catheters, guidewires, sheaths and sheath introducers, accessories, and others. Catheters are further divided into cardiovascular catheters, specialty catheters, intravenous catheters, urinary catheters, and neurological catheters. Guidewires are further classified as solid guidewire and wrapped guidewire.

Based on application, the global transradial access devices market is classified as drug administration, fluid and nutrition administration, blood transfusion, and diagnostics and testing.

Based on disease area, the global transradial access devices market is classified as cardiovascular diseases, cancer, rheumatoid arthritis, ischemic stroke, endometriosis, and others.

Based on end-user, the global transradial access devices market is classified as hospitals, clinics, ambulatory care centers, and others.

Key Players

Some of the key players in the global transradial access devices market are Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), Teleflex Incorporated (US), Smiths Group Plc (UK), Edward Lifesciences Corporation (US), Medtronic Plc (Ireland), Merit Medical System, Inc. (US), Boston Scientific Corporation (US), NIPRO Medical Corporation (US), AngioDynamics (US), Ameco Medical Industries (Egypt), OSCOR Inc. (US), and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com